CHULALONGKORN UNIVERSITY
🇹🇭Thailand
- Country
- 🇹🇭Thailand
- Ownership
- -
- Established
- 1917-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.chula.ac.th/
Clinical Trials
407
Active:12
Completed:216
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:40
Phase 2:39
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (330 trials with phase data)• Click on a phase to view related trials
Not Applicable
168 (50.9%)Phase 4
46 (13.9%)Phase 1
40 (12.1%)Phase 2
39 (11.8%)Phase 3
36 (10.9%)Early Phase 1
1 (0.3%)The Optimal Protein Intake to Enhance Muscle Mass in Elderly Patients With Pre-dialysis Chronic Kidney Disease
Not Applicable
- Conditions
- SarcopeniaChronic Kidney Disease
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 60
- Registration Number
- NCT07102667
- Locations
- 🇹🇭
King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
Not Applicable
Not yet recruiting
- Conditions
- Menstruation DisturbancesContraception BehaviorMetrorrhagiaUterine Hemorrhage
- Interventions
- Drug: Transdermal Ethinyl Estradiol/Norelgestromin PatchDrug: Placebo Patch
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 40
- Registration Number
- NCT07083635
Phase I Clinical Trial of CMD63 CAR T Cell in Children With Acute Lymphoblastic Leukemia
Not Applicable
Not yet recruiting
- Conditions
- Relapse B Acute Lymphoblastic LeukemiaRefactory Childhood Acute Lymphoblastic Leukemia
- Interventions
- Biological: CD19-IL7Ra CAR-T cells
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 16
- Registration Number
- NCT07078929
- Locations
- 🇹🇭
King Chulalongkorn Memorial Hospital, Bangkok, Pathumwan, Thailand
Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Pregnant Women Undergoing Cesarean Section
Not Applicable
Not yet recruiting
- Conditions
- Pregnant Women Undergoing Cesarean Delivery
- Interventions
- Other: Placebo
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 98
- Registration Number
- NCT07078942
- Locations
- 🇹🇭
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip Hyperpigmentation
Not Applicable
Recruiting
- Conditions
- Hyperpigmentation
- First Posted Date
- 2025-07-16
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 30
- Registration Number
- NCT07067879
- Locations
- 🇹🇭
Faculty of dentistry, Chulalongkorn university, Bangkok, Thailand
- Prev
- 1
- 2
- 3
- 4
- 5
- 58
- Next
News
No news found